10 Biggest Price Target Changes For Thursday
Barclays cut the price target for Splunk Inc. (NASDAQ: SPLK) from $206 to $170. Splunk shares fell 4.8% to $117.90 in pre-market trading.
Baird Downgrades Progenity to Neutral, Lowers Price Target to $2
Baird analyst Catherine Schulte downgrades Progenity (NASDAQ:PROG) from Outperform to Neutral and lowers the price target from $4 to $2.
Progenity to Close Genetic Test Services, Focus Shifts to Therapeutics
Women’s health diagnostic firm, Progenity Inc (NASDAQ: PROG), will close its genetics laboratory as part of a strategic transformation that emphasizes its drug…
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously disclosed heavily pretreated advanced breast cancer patients.
Progenity Provides Results From Key Study For Its Targeted Therapeutics Program
Progenity, Inc. (NASDAQ:PROG), an innovative biotechnology company, today announced results from a further study for the company's Targeted Therapeutics program. The study evaluated delivery of Progenity's
60 Biggest Movers From Yesterday
Gainers
Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 19 companies hit new 52-week lows.